Russia starts testing coronavirus vaccines as cases continue to rise

As world is racing to develop a vaccine for vel coronavirus, Russian consumer rights watchdog Rospotrebnzor has launched tests of a potential vaccine. According to Russian state news ncy, watchdog’s State Research Center of Virology and Biotechlogy Vector has developed protos of vaccines based on six various techlogical platforms.

Rospotrebnzor reportedly said that it is necessary to carry out Vivo tests on sensitive laboratory animals. scientists have developed vaccine based on broly used recombinant viral vectors of flu and tests will determine dose, frequency and methods of application.

Re: Donald Trump Claims Of Slashing Red Tape To Develop Vaccines amid Coronavirus Outbreak

Researchers have started developing a potential vaccine for COVID-19 and World Health Organisation (WHO) chief has highlighted first vaccine trial by United States, just 60 days after genetic sequence of virus was shared by China. Calling it an incredible achievement, he commended researchers around world who have come toger to systemically evaluate experimental rapeutics.

re has been also fear of United States mopolising vaccine after reports of US President Donald Trump wanting to get exclusive access to a potential coronavirus vaccine developed by a German biotech firm emerged. However, Germany’s Finance Minister Heiko Maas publicly denied any intention to sell rights to coronavirus vaccine research.

Re: Coronavirus Vaccine: Hoffenheim Owner Rejects Donald Trump's Lucrative Privatization Offer

' exclusive rights'

Local media reports suggested that Trump h offered “a billion dollars” to secure exclusive rights over research into a vaccine by German biotech firm CureVac. Speaking to a German media group Funke, foreign minister said that researchers play a leing role in drug and vaccine development and ministration cant allow ors to seek exclusive results.

company, in a statement, abstained from commenting on “speculations” and rejected “rumours” of acquisition saying it is focussed on development of mRNA-based coronavirus vaccine to protect people worldwide. “Based on its inherent mode of action, CureVac sees mRNA as one of most potent molecules to provide fast and efficient solutions in outbreak scenarios, such like Coronavirus (sic),” biotech firm.

Re: G7 Holds Emergency Video Summit On Coronavirus, Slams US Attempt To Mopolise Vaccine

Re: Germany Denies Possible Sale Of Exclusive Coronavirus Vaccine Rights To US